tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
:PAR
Australian Market
Advertisement

Paradigm Biopharmaceuticals (PAR) Income Statement

Compare
37 Followers

Paradigm Biopharmaceuticals Income Statement

Last quarter (Q4 2025), Paradigm Biopharmaceuticals's total revenue was AU$35.42K, a decrease of -15.77% from the same quarter last year. In Q4, Paradigm Biopharmaceuticals's net income was AU$-12.85M. See Paradigm Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 52.12KAU$ 65.80KAU$ 46.76KAU$ 79.22KAU$ 20.55K
Gross Profit
AU$ -19.89KAU$ 56.81KAU$ -18.83KAU$ -64.53KAU$ -78.59K
Operating Expenses
AU$ 22.87MAU$ 65.10MAU$ 60.07MAU$ 47.93MAU$ 43.31M
Depreciation and Amortization
AU$ 51.42KAU$ 146.74KAU$ 153.66KAU$ 193.25KAU$ 210.06K
EBITDA
AU$ -25.25MAU$ -64.54MAU$ -59.06MAU$ -46.82MAU$ -42.40M
Operating Income
AU$ -22.89MAU$ -65.19MAU$ -59.22MAU$ -47.01MAU$ -42.34M
Other Income/Expenses
AU$ -2.42MAU$ 6.54MAU$ 263.61KAU$ -1.48KAU$ -302.21K
Pretax Income
AU$ -25.30MAU$ -58.65MAU$ -58.95MAU$ -47.01MAU$ -42.65M
Net Income
AU$ -18.77MAU$ -58.65MAU$ -51.91MAU$ -39.25MAU$ -34.30M
Per Share Metrics
Basic EPS
AU$ -0.06AU$ -0.20AU$ -0.18AU$ -0.16AU$ -0.16
Diluted EPS
AU$ -0.06AU$ -0.20AU$ -0.18AU$ -0.16AU$ -0.16
Weighted Average Shares Outstanding
314.50M 293.28M 289.68M 240.96M 212.19M
Weighted Average Shares Outstanding (Diluted)
314.50M 293.28M 289.68M 241.82M 212.19M
Currency in AUD

Paradigm Biopharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis